TheraRadar
← Back
Data updated: Mar 29, 2026

NUVO PHARMS INC

ImmunologyGastroenterology
Generics

NUVO PHARMS INC is a generic drug manufacturer focused on Immunology, Gastroenterology.

1998
Since
11
Drugs
-
Trials
28
Approved (2yr)

Key Drugs

CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
chlordiazepoxide hydrochloride
4 indications · 2020

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

HYDROXYZINE HYDROCHLORIDE 2025-12-16
SULFASALAZINE 2025-11-04
NAPROXEN 2025-10-03
NAPROXEN 2025-08-28
Labeling
FOLIC ACID 2025-08-13
Labeling
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 2025-08-04
Labeling
NAPROXEN 2025-06-13
Labeling
NAPROXEN 2025-06-13
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 50%
1 drugs
Gastroenterology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Immunology, Gastroenterology
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology
BAUSCH specialty
Immunology, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology
Gilead Sciences biotech
Immunology, Gastroenterology